An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Explore the revolutionary potential of Lorlatinib, a third-generation ALK-TKI, through the CROWN trial with Dr. Vamshi Krishna M.

Speakers : Dr. Vamsi Krishna M

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Explore the unmet needs in ALK-positive NSCLC with Dr. Vamshi Krishna M as he discusses current challenges, treatment gaps, and future directions in lung cancer care.

Speakers : Dr. Vamsi Krishna M

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

In this webinar, a detailed discussion is done on Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Speakers : Dr. Sushant Mittal - Moderator ,Dr. Randeep Singh - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Davinder Paul - Panelist

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

Early management of CNS metastases in ALK-positive NSCLC using next-gen ALK inhibitors improves intracranial control and patient outcomes.

Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

Explore innovative strategies for early CNS disease detection, integrating neuroimaging, biomarkers, and clinical assessment to enhance diagnostic precision and outcomes.

Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

Explore Lorlatinib’s role in first-line ALK+ mNSCLC treatment, highlighting key findings from the CROWN trial.`

Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

In this webinar, a detailed discussion is done on Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

Explore treatment sequencing strategies for ALK+ NSCLC patients with CNS diseases, focusing on targeted therapies and CNS-penetrant treatments.

Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

Explore unmet needs in ALK-positive NSCLC, including resistance, CNS metastases, biomarker-driven therapies, and advances in precision oncology.

Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

Explore key findings from the CROWN trial for ALK+ NSCLC patients with CNS metastases and treatment advances.

Speakers : Dr. Sushant Mittal - Moderator ,Dr. Randeep Singh - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Davinder Paul - Panelist


Recommended News For You

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

AI tool accurately detects tumor location on breast MRI

Cancer detection recovered following pandemic disruptions

Recommended Articles For You

Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders 

The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease  

Unveiling the Mystery Behind Lymphovascular Invasion 

Molecular & Genetic Oncology: Emerging Frontiers in 2025 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

5.

Two medications might work better for breast cancers that are resistant to one.

1.

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology

2.

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease 

3.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

4.

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies

5.

Exploring the Mysteries of Myxoma: A New Frontier in Medical Research

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Thromboprophylaxis In Medical Settings

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot